nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—Tafluprost—PTGS2—pancreatic cancer	0.00273	1	CrCbGaD
Carboprost Tromethamine—Hiccups—Epirubicin—pancreatic cancer	0.00172	0.00333	CcSEcCtD
Carboprost Tromethamine—Flushing—Irinotecan—pancreatic cancer	0.00172	0.00333	CcSEcCtD
Carboprost Tromethamine—Cough—Sunitinib—pancreatic cancer	0.0017	0.00331	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.0017	0.00329	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Docetaxel—pancreatic cancer	0.00169	0.00327	CcSEcCtD
Carboprost Tromethamine—Hypertension—Sunitinib—pancreatic cancer	0.00169	0.00327	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00168	0.00326	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Tamoxifen—pancreatic cancer	0.00167	0.00324	CcSEcCtD
Carboprost Tromethamine—Chest pain—Sunitinib—pancreatic cancer	0.00166	0.00323	CcSEcCtD
Carboprost Tromethamine—Myalgia—Sunitinib—pancreatic cancer	0.00166	0.00323	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00166	0.00322	CcSEcCtD
Carboprost Tromethamine—Chills—Irinotecan—pancreatic cancer	0.00166	0.00322	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Erlotinib—pancreatic cancer	0.00164	0.00319	CcSEcCtD
Carboprost Tromethamine—Chills—Gemcitabine—pancreatic cancer	0.00162	0.00314	CcSEcCtD
Carboprost Tromethamine—Pain—Tamoxifen—pancreatic cancer	0.00159	0.00309	CcSEcCtD
Carboprost Tromethamine—Hiccups—Doxorubicin—pancreatic cancer	0.00159	0.00308	CcSEcCtD
Carboprost Tromethamine—Infection—Sunitinib—pancreatic cancer	0.00158	0.00307	CcSEcCtD
Carboprost Tromethamine—Cramps of lower extremities—Epirubicin—pancreatic cancer	0.00158	0.00306	CcSEcCtD
Carboprost Tromethamine—Pain—Erlotinib—pancreatic cancer	0.00157	0.00306	CcSEcCtD
Carboprost Tromethamine—Shock—Sunitinib—pancreatic cancer	0.00157	0.00305	CcSEcCtD
Carboprost Tromethamine—Back pain—Irinotecan—pancreatic cancer	0.00156	0.00302	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Irinotecan—pancreatic cancer	0.00155	0.003	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Epirubicin—pancreatic cancer	0.00153	0.00297	CcSEcCtD
Carboprost Tromethamine—Back pain—Gemcitabine—pancreatic cancer	0.00152	0.00294	CcSEcCtD
Carboprost Tromethamine—Cramps of lower extremities—Doxorubicin—pancreatic cancer	0.00146	0.00283	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Erlotinib—pancreatic cancer	0.00146	0.00283	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00145	0.00282	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Fluorouracil—pancreatic cancer	0.00145	0.00282	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Epirubicin—pancreatic cancer	0.00145	0.00281	CcSEcCtD
Carboprost Tromethamine—Vertigo—Irinotecan—pancreatic cancer	0.00145	0.00281	CcSEcCtD
Carboprost Tromethamine—Syncope—Irinotecan—pancreatic cancer	0.00144	0.0028	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Sunitinib—pancreatic cancer	0.00143	0.00278	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Sunitinib—pancreatic cancer	0.00142	0.00276	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Irinotecan—pancreatic cancer	0.00141	0.00275	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.00141	0.00274	CcSEcCtD
Carboprost Tromethamine—Cough—Irinotecan—pancreatic cancer	0.0014	0.00273	CcSEcCtD
Carboprost Tromethamine—Hypertension—Irinotecan—pancreatic cancer	0.00139	0.0027	CcSEcCtD
Carboprost Tromethamine—Eye pain—Epirubicin—pancreatic cancer	0.00138	0.00268	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00137	0.00266	CcSEcCtD
Carboprost Tromethamine—Cough—Gemcitabine—pancreatic cancer	0.00137	0.00266	CcSEcCtD
Carboprost Tromethamine—Pain—Sunitinib—pancreatic cancer	0.00136	0.00265	CcSEcCtD
Carboprost Tromethamine—Hypertension—Gemcitabine—pancreatic cancer	0.00135	0.00263	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Docetaxel—pancreatic cancer	0.00134	0.00261	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Doxorubicin—pancreatic cancer	0.00134	0.0026	CcSEcCtD
Carboprost Tromethamine—Asthenia—Tamoxifen—pancreatic cancer	0.00134	0.00259	CcSEcCtD
Carboprost Tromethamine—Chest pain—Gemcitabine—pancreatic cancer	0.00133	0.00259	CcSEcCtD
Carboprost Tromethamine—Myalgia—Gemcitabine—pancreatic cancer	0.00133	0.00259	CcSEcCtD
Carboprost Tromethamine—Hot flush—Epirubicin—pancreatic cancer	0.00133	0.00259	CcSEcCtD
Carboprost Tromethamine—Asthenia—Erlotinib—pancreatic cancer	0.00132	0.00257	CcSEcCtD
Carboprost Tromethamine—Menopausal symptoms—Epirubicin—pancreatic cancer	0.00132	0.00256	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00131	0.00255	CcSEcCtD
Carboprost Tromethamine—Chest pain—Fluorouracil—pancreatic cancer	0.00131	0.00255	CcSEcCtD
Carboprost Tromethamine—Myalgia—Fluorouracil—pancreatic cancer	0.00131	0.00255	CcSEcCtD
Carboprost Tromethamine—Infection—Irinotecan—pancreatic cancer	0.0013	0.00253	CcSEcCtD
Carboprost Tromethamine—Shock—Irinotecan—pancreatic cancer	0.00129	0.00251	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00129	0.0025	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00128	0.00248	CcSEcCtD
Carboprost Tromethamine—Eye pain—Doxorubicin—pancreatic cancer	0.00128	0.00248	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Tamoxifen—pancreatic cancer	0.00127	0.00247	CcSEcCtD
Carboprost Tromethamine—Lethargy—Epirubicin—pancreatic cancer	0.00127	0.00247	CcSEcCtD
Carboprost Tromethamine—Infection—Gemcitabine—pancreatic cancer	0.00127	0.00247	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00127	0.00246	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Sunitinib—pancreatic cancer	0.00126	0.00245	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Erlotinib—pancreatic cancer	0.00126	0.00245	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00126	0.00244	CcSEcCtD
Carboprost Tromethamine—Infection—Fluorouracil—pancreatic cancer	0.00125	0.00243	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00124	0.0024	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.00124	0.00256	CbGpPWpGaD
Carboprost Tromethamine—Hot flush—Doxorubicin—pancreatic cancer	0.00123	0.00239	CcSEcCtD
Carboprost Tromethamine—Dizziness—Tamoxifen—pancreatic cancer	0.00123	0.00239	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Fluorouracil—pancreatic cancer	0.00123	0.00238	CcSEcCtD
Carboprost Tromethamine—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.00122	0.00237	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCKBR—pancreatic cancer	0.00122	0.00253	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Erlotinib—pancreatic cancer	0.00122	0.00236	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—SSTR3—pancreatic cancer	0.00122	0.00252	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.00119	0.00247	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—SSTR1—pancreatic cancer	0.00119	0.00247	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00119	0.00231	CcSEcCtD
Carboprost Tromethamine—Flushing—Docetaxel—pancreatic cancer	0.00119	0.0023	CcSEcCtD
Carboprost Tromethamine—Vomiting—Tamoxifen—pancreatic cancer	0.00118	0.0023	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Irinotecan—pancreatic cancer	0.00118	0.00229	CcSEcCtD
Carboprost Tromethamine—Lethargy—Doxorubicin—pancreatic cancer	0.00118	0.00228	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Sunitinib—pancreatic cancer	0.00117	0.00228	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CNR1—pancreatic cancer	0.00117	0.00243	CbGpPWpGaD
Carboprost Tromethamine—Rash—Tamoxifen—pancreatic cancer	0.00117	0.00228	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Tamoxifen—pancreatic cancer	0.00117	0.00228	CcSEcCtD
Carboprost Tromethamine—Vomiting—Erlotinib—pancreatic cancer	0.00117	0.00227	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Irinotecan—pancreatic cancer	0.00117	0.00227	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PPY—pancreatic cancer	0.00117	0.00242	CbGpPWpGaD
Carboprost Tromethamine—Somnolence—Irinotecan—pancreatic cancer	0.00117	0.00227	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—SSTR1—pancreatic cancer	0.00117	0.00242	CbGpPWpGaD
Carboprost Tromethamine—Headache—Tamoxifen—pancreatic cancer	0.00117	0.00226	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00117	0.00226	CcSEcCtD
Carboprost Tromethamine—Rash—Erlotinib—pancreatic cancer	0.00116	0.00225	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Erlotinib—pancreatic cancer	0.00116	0.00225	CcSEcCtD
Carboprost Tromethamine—Headache—Erlotinib—pancreatic cancer	0.00115	0.00224	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CNR1—pancreatic cancer	0.00115	0.00238	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Gemcitabine—pancreatic cancer	0.00115	0.00223	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—SSTR2—pancreatic cancer	0.00115	0.00238	CbGpPWpGaD
Carboprost Tromethamine—Chills—Docetaxel—pancreatic cancer	0.00115	0.00223	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00115	0.00222	CcSEcCtD
Carboprost Tromethamine—Asthenia—Sunitinib—pancreatic cancer	0.00114	0.00222	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PPY—pancreatic cancer	0.00114	0.00237	CbGpPWpGaD
Carboprost Tromethamine—Dyspnoea—Gemcitabine—pancreatic cancer	0.00114	0.00221	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.00114	0.00221	CcSEcCtD
Carboprost Tromethamine—Somnolence—Gemcitabine—pancreatic cancer	0.00114	0.00221	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GCG—pancreatic cancer	0.00113	0.00235	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Fluorouracil—pancreatic cancer	0.00113	0.00219	CcSEcCtD
Carboprost Tromethamine—Pain—Irinotecan—pancreatic cancer	0.00112	0.00218	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—SSTR2—pancreatic cancer	0.00112	0.00233	CbGpPWpGaD
Carboprost Tromethamine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00112	0.00218	CcSEcCtD
Carboprost Tromethamine—Somnolence—Fluorouracil—pancreatic cancer	0.00112	0.00217	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GCG—pancreatic cancer	0.00111	0.0023	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCKBR—pancreatic cancer	0.00111	0.0023	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Tamoxifen—pancreatic cancer	0.00111	0.00215	CcSEcCtD
Carboprost Tromethamine—Pain—Gemcitabine—pancreatic cancer	0.00109	0.00212	CcSEcCtD
Carboprost Tromethamine—Nausea—Erlotinib—pancreatic cancer	0.00109	0.00212	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Sunitinib—pancreatic cancer	0.00109	0.00212	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCKBR—pancreatic cancer	0.00108	0.00225	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—AGTR1—pancreatic cancer	0.00108	0.00224	CbGpPWpGaD
Carboprost Tromethamine—Asthma—Epirubicin—pancreatic cancer	0.00108	0.00209	CcSEcCtD
Carboprost Tromethamine—Back pain—Docetaxel—pancreatic cancer	0.00108	0.00209	CcSEcCtD
Carboprost Tromethamine—Pain—Fluorouracil—pancreatic cancer	0.00108	0.00209	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Docetaxel—pancreatic cancer	0.00107	0.00208	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—AGTR1—pancreatic cancer	0.00106	0.00219	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Sunitinib—pancreatic cancer	0.00105	0.00205	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.00105	0.00204	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GAST—pancreatic cancer	0.00105	0.00217	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Irinotecan—pancreatic cancer	0.00104	0.00202	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GAST—pancreatic cancer	0.00103	0.00213	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Sunitinib—pancreatic cancer	0.00101	0.00197	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Gemcitabine—pancreatic cancer	0.00101	0.00196	CcSEcCtD
Carboprost Tromethamine—Rash—Sunitinib—pancreatic cancer	0.001	0.00195	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Sunitinib—pancreatic cancer	0.001	0.00195	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.001	0.00194	CcSEcCtD
Carboprost Tromethamine—Headache—Sunitinib—pancreatic cancer	0.000998	0.00194	CcSEcCtD
Carboprost Tromethamine—Syncope—Docetaxel—pancreatic cancer	0.000997	0.00194	CcSEcCtD
Carboprost Tromethamine—Asthma—Doxorubicin—pancreatic cancer	0.000996	0.00193	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—SCT—pancreatic cancer	0.000994	0.00206	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000994	0.00193	CcSEcCtD
Carboprost Tromethamine—Palpitations—Docetaxel—pancreatic cancer	0.000983	0.00191	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000977	0.0019	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—SCT—pancreatic cancer	0.000973	0.00202	CbGpPWpGaD
Carboprost Tromethamine—Cough—Docetaxel—pancreatic cancer	0.00097	0.00188	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000967	0.00188	CcSEcCtD
Carboprost Tromethamine—Hypertension—Docetaxel—pancreatic cancer	0.00096	0.00186	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Epirubicin—pancreatic cancer	0.00096	0.00186	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GAST—pancreatic cancer	0.000952	0.00197	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCK—pancreatic cancer	0.000948	0.00197	CbGpPWpGaD
Carboprost Tromethamine—Myalgia—Docetaxel—pancreatic cancer	0.000947	0.00184	CcSEcCtD
Carboprost Tromethamine—Chest pain—Docetaxel—pancreatic cancer	0.000947	0.00184	CcSEcCtD
Carboprost Tromethamine—Nausea—Sunitinib—pancreatic cancer	0.000947	0.00184	CcSEcCtD
Carboprost Tromethamine—Asthenia—Irinotecan—pancreatic cancer	0.000942	0.00183	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000933	0.00181	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GAST—pancreatic cancer	0.000932	0.00193	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCK—pancreatic cancer	0.000928	0.00192	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000926	0.0018	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000926	0.0018	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000924	0.00192	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CNR2—pancreatic cancer	0.000924	0.00192	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Gemcitabine—pancreatic cancer	0.000918	0.00178	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000909	0.00189	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000908	0.00176	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Epirubicin—pancreatic cancer	0.000905	0.00176	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CNR2—pancreatic cancer	0.000905	0.00188	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000905	0.00188	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—SCT—pancreatic cancer	0.000903	0.00187	CbGpPWpGaD
Carboprost Tromethamine—Infection—Docetaxel—pancreatic cancer	0.000902	0.00175	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Irinotecan—pancreatic cancer	0.000898	0.00174	CcSEcCtD
Carboprost Tromethamine—Shock—Docetaxel—pancreatic cancer	0.000893	0.00173	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.00089	0.00185	CbGpPWpGaD
Carboprost Tromethamine—Drowsiness—Doxorubicin—pancreatic cancer	0.000888	0.00172	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Docetaxel—pancreatic cancer	0.000886	0.00172	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—SCT—pancreatic cancer	0.000884	0.00183	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000875	0.0017	CcSEcCtD
Carboprost Tromethamine—Dizziness—Irinotecan—pancreatic cancer	0.000868	0.00169	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000863	0.00168	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PRLHR—pancreatic cancer	0.000863	0.00179	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCK—pancreatic cancer	0.000861	0.00179	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00086	0.00167	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PRLHR—pancreatic cancer	0.000845	0.00175	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCK—pancreatic cancer	0.000843	0.00175	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CNR2—pancreatic cancer	0.000839	0.00174	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GLP1R—pancreatic cancer	0.000839	0.00174	CbGpPWpGaD
Carboprost Tromethamine—Epistaxis—Doxorubicin—pancreatic cancer	0.000838	0.00163	CcSEcCtD
Carboprost Tromethamine—Vomiting—Irinotecan—pancreatic cancer	0.000835	0.00162	CcSEcCtD
Carboprost Tromethamine—Dizziness—Fluorouracil—pancreatic cancer	0.000832	0.00161	CcSEcCtD
Carboprost Tromethamine—Rash—Irinotecan—pancreatic cancer	0.000828	0.00161	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Irinotecan—pancreatic cancer	0.000827	0.00161	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000827	0.00161	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCKAR—pancreatic cancer	0.000826	0.00171	CbGpPWpGaD
Carboprost Tromethamine—Headache—Irinotecan—pancreatic cancer	0.000822	0.0016	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CNR2—pancreatic cancer	0.000821	0.0017	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000821	0.0017	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—IAPP—pancreatic cancer	0.000819	0.0017	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Docetaxel—pancreatic cancer	0.000815	0.00158	CcSEcCtD
Carboprost Tromethamine—Vomiting—Gemcitabine—pancreatic cancer	0.000813	0.00158	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ACVR1B—pancreatic cancer	0.000812	0.00168	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ZNRF3—pancreatic cancer	0.000812	0.00168	CbGpPWpGaD
Carboprost Tromethamine—Dyspnoea—Docetaxel—pancreatic cancer	0.000809	0.00157	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000808	0.00168	CbGpPWpGaD
Carboprost Tromethamine—Somnolence—Docetaxel—pancreatic cancer	0.000807	0.00157	CcSEcCtD
Carboprost Tromethamine—Rash—Gemcitabine—pancreatic cancer	0.000806	0.00157	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Gemcitabine—pancreatic cancer	0.000806	0.00156	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Epirubicin—pancreatic cancer	0.000803	0.00156	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—IAPP—pancreatic cancer	0.000801	0.00166	CbGpPWpGaD
Carboprost Tromethamine—Headache—Gemcitabine—pancreatic cancer	0.000801	0.00156	CcSEcCtD
Carboprost Tromethamine—Flushing—Epirubicin—pancreatic cancer	0.0008	0.00155	CcSEcCtD
Carboprost Tromethamine—Vomiting—Fluorouracil—pancreatic cancer	0.000799	0.00155	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000794	0.00165	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000794	0.00165	CbGpPWpGaD
Carboprost Tromethamine—Rash—Fluorouracil—pancreatic cancer	0.000793	0.00154	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Fluorouracil—pancreatic cancer	0.000792	0.00154	CcSEcCtD
Carboprost Tromethamine—Headache—Fluorouracil—pancreatic cancer	0.000788	0.00153	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000786	0.00163	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Irinotecan—pancreatic cancer	0.00078	0.00151	CcSEcCtD
Carboprost Tromethamine—Pain—Docetaxel—pancreatic cancer	0.000776	0.00151	CcSEcCtD
Carboprost Tromethamine—Chills—Epirubicin—pancreatic cancer	0.000773	0.0015	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000769	0.00159	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Gemcitabine—pancreatic cancer	0.00076	0.00148	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—SHH—pancreatic cancer	0.000753	0.00156	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Fluorouracil—pancreatic cancer	0.000747	0.00145	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IAPP—pancreatic cancer	0.000743	0.00154	CbGpPWpGaD
Carboprost Tromethamine—Tinnitus—Doxorubicin—pancreatic cancer	0.000743	0.00144	CcSEcCtD
Carboprost Tromethamine—Flushing—Doxorubicin—pancreatic cancer	0.00074	0.00144	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—SHH—pancreatic cancer	0.000737	0.00153	CbGpPWpGaD
Carboprost Tromethamine—Tension—Epirubicin—pancreatic cancer	0.000736	0.00143	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SSTR3—pancreatic cancer	0.000734	0.00152	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DTX1—pancreatic cancer	0.000734	0.00152	CbGpPWpGaD
Carboprost Tromethamine—Nervousness—Epirubicin—pancreatic cancer	0.000728	0.00141	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IAPP—pancreatic cancer	0.000728	0.00151	CbGpPWpGaD
Carboprost Tromethamine—Back pain—Epirubicin—pancreatic cancer	0.000726	0.00141	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Epirubicin—pancreatic cancer	0.000721	0.0014	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—SST—pancreatic cancer	0.000719	0.00149	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SSTR3—pancreatic cancer	0.000718	0.00149	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DTX1—pancreatic cancer	0.000718	0.00149	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Docetaxel—pancreatic cancer	0.000717	0.00139	CcSEcCtD
Carboprost Tromethamine—Chills—Doxorubicin—pancreatic cancer	0.000715	0.00139	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTHLH—pancreatic cancer	0.000714	0.00148	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTCH1—pancreatic cancer	0.000714	0.00148	CbGpPWpGaD
Carboprost Tromethamine—Vision blurred—Epirubicin—pancreatic cancer	0.000707	0.00137	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000705	0.00146	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SSTR1—pancreatic cancer	0.000704	0.00146	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—SST—pancreatic cancer	0.000703	0.00146	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000698	0.00145	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000698	0.00145	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PPY—pancreatic cancer	0.00069	0.00143	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.00069	0.00143	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SSTR1—pancreatic cancer	0.000689	0.00143	CbGpPWpGaD
Carboprost Tromethamine—Tension—Doxorubicin—pancreatic cancer	0.000681	0.00132	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SSTR2—pancreatic cancer	0.000677	0.0014	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PPY—pancreatic cancer	0.000675	0.0014	CbGpPWpGaD
Carboprost Tromethamine—Nervousness—Doxorubicin—pancreatic cancer	0.000674	0.00131	CcSEcCtD
Carboprost Tromethamine—Vertigo—Epirubicin—pancreatic cancer	0.000674	0.00131	CcSEcCtD
Carboprost Tromethamine—Syncope—Epirubicin—pancreatic cancer	0.000673	0.00131	CcSEcCtD
Carboprost Tromethamine—Back pain—Doxorubicin—pancreatic cancer	0.000671	0.0013	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000669	0.0013	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000667	0.0013	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CNR1—pancreatic cancer	0.000663	0.00138	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SSTR2—pancreatic cancer	0.000663	0.00137	CbGpPWpGaD
Carboprost Tromethamine—Palpitations—Epirubicin—pancreatic cancer	0.000663	0.00129	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000659	0.00128	CcSEcCtD
Carboprost Tromethamine—Cough—Epirubicin—pancreatic cancer	0.000655	0.00127	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCKBR—pancreatic cancer	0.000654	0.00136	CbGpPWpGaD
Carboprost Tromethamine—Vision blurred—Doxorubicin—pancreatic cancer	0.000654	0.00127	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—SST—pancreatic cancer	0.000653	0.00135	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Docetaxel—pancreatic cancer	0.000651	0.00126	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000651	0.00135	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000649	0.00135	CbGpPWpGaD
Carboprost Tromethamine—Hypertension—Epirubicin—pancreatic cancer	0.000648	0.00126	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000642	0.00133	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GCG—pancreatic cancer	0.000641	0.00133	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCKBR—pancreatic cancer	0.00064	0.00133	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—SST—pancreatic cancer	0.000639	0.00132	CbGpPWpGaD
Carboprost Tromethamine—Chest pain—Epirubicin—pancreatic cancer	0.000639	0.00124	CcSEcCtD
Carboprost Tromethamine—Myalgia—Epirubicin—pancreatic cancer	0.000639	0.00124	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000637	0.00132	CbGpPWpGaD
Carboprost Tromethamine—Anxiety—Epirubicin—pancreatic cancer	0.000636	0.00124	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000629	0.0013	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GCG—pancreatic cancer	0.000627	0.0013	CbGpPWpGaD
Carboprost Tromethamine—Vertigo—Doxorubicin—pancreatic cancer	0.000624	0.00121	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000623	0.00129	CbGpPWpGaD
Carboprost Tromethamine—Syncope—Doxorubicin—pancreatic cancer	0.000622	0.00121	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Docetaxel—pancreatic cancer	0.000621	0.00121	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DTX4—pancreatic cancer	0.000615	0.00128	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GLI1—pancreatic cancer	0.000615	0.00128	CbGpPWpGaD
Carboprost Tromethamine—Palpitations—Doxorubicin—pancreatic cancer	0.000613	0.00119	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000612	0.00119	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000611	0.00127	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.00061	0.00126	CbGpPWpGaD
Carboprost Tromethamine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00061	0.00118	CcSEcCtD
Carboprost Tromethamine—Infection—Epirubicin—pancreatic cancer	0.000608	0.00118	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000607	0.00126	CbGpPWpGaD
Carboprost Tromethamine—Cough—Doxorubicin—pancreatic cancer	0.000606	0.00118	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CNR1—pancreatic cancer	0.000602	0.00125	CbGpPWpGaD
Carboprost Tromethamine—Shock—Epirubicin—pancreatic cancer	0.000602	0.00117	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GLI1—pancreatic cancer	0.000602	0.00125	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DTX4—pancreatic cancer	0.000602	0.00125	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Docetaxel—pancreatic cancer	0.0006	0.00117	CcSEcCtD
Carboprost Tromethamine—Hypertension—Doxorubicin—pancreatic cancer	0.000599	0.00116	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NRP1—pancreatic cancer	0.000598	0.00124	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000598	0.00124	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000598	0.00124	CbGpPWpGaD
Carboprost Tromethamine—Tachycardia—Epirubicin—pancreatic cancer	0.000597	0.00116	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000594	0.00123	CbGpPWpGaD
Carboprost Tromethamine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000592	0.00115	CcSEcCtD
Carboprost Tromethamine—Myalgia—Doxorubicin—pancreatic cancer	0.000591	0.00115	CcSEcCtD
Carboprost Tromethamine—Chest pain—Doxorubicin—pancreatic cancer	0.000591	0.00115	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CNR1—pancreatic cancer	0.00059	0.00122	CbGpPWpGaD
Carboprost Tromethamine—Anxiety—Doxorubicin—pancreatic cancer	0.000589	0.00114	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NRP1—pancreatic cancer	0.000586	0.00121	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000586	0.00121	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GCG—pancreatic cancer	0.000582	0.00121	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Docetaxel—pancreatic cancer	0.000577	0.00112	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HEY2—pancreatic cancer	0.000576	0.00119	CbGpPWpGaD
Carboprost Tromethamine—Rash—Docetaxel—pancreatic cancer	0.000572	0.00111	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Docetaxel—pancreatic cancer	0.000572	0.00111	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GCG—pancreatic cancer	0.000569	0.00118	CbGpPWpGaD
Carboprost Tromethamine—Headache—Docetaxel—pancreatic cancer	0.000569	0.0011	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000566	0.0011	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HEY2—pancreatic cancer	0.000564	0.00117	CbGpPWpGaD
Carboprost Tromethamine—Infection—Doxorubicin—pancreatic cancer	0.000563	0.00109	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GAST—pancreatic cancer	0.000563	0.00117	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000558	0.00108	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000557	0.00116	CbGpPWpGaD
Carboprost Tromethamine—Shock—Doxorubicin—pancreatic cancer	0.000557	0.00108	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AGTR1—pancreatic cancer	0.000555	0.00115	CbGpPWpGaD
Carboprost Tromethamine—Tachycardia—Doxorubicin—pancreatic cancer	0.000553	0.00107	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GAST—pancreatic cancer	0.000551	0.00114	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Epirubicin—pancreatic cancer	0.00055	0.00107	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000548	0.00106	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Epirubicin—pancreatic cancer	0.000546	0.00106	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000546	0.00113	CbGpPWpGaD
Carboprost Tromethamine—Somnolence—Epirubicin—pancreatic cancer	0.000544	0.00106	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000543	0.00113	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Docetaxel—pancreatic cancer	0.000539	0.00105	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SCT—pancreatic cancer	0.000533	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HEY1—pancreatic cancer	0.000533	0.00111	CbGpPWpGaD
Carboprost Tromethamine—Pain—Epirubicin—pancreatic cancer	0.000523	0.00102	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SCT—pancreatic cancer	0.000522	0.00108	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HEY1—pancreatic cancer	0.000522	0.00108	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000516	0.001	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000516	0.00107	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCK—pancreatic cancer	0.000509	0.00105	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000509	0.000988	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000505	0.000981	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000505	0.00105	CbGpPWpGaD
Carboprost Tromethamine—Somnolence—Doxorubicin—pancreatic cancer	0.000504	0.000978	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCK—pancreatic cancer	0.000498	0.00103	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CNR2—pancreatic cancer	0.000496	0.00103	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GLP1R—pancreatic cancer	0.000496	0.00103	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCL8—pancreatic cancer	0.000495	0.00103	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCKAR—pancreatic cancer	0.000488	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CNR2—pancreatic cancer	0.000485	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GLP1R—pancreatic cancer	0.000485	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000485	0.00101	CbGpPWpGaD
Carboprost Tromethamine—Pain—Doxorubicin—pancreatic cancer	0.000484	0.000941	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Epirubicin—pancreatic cancer	0.000484	0.00094	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCKAR—pancreatic cancer	0.000477	0.00099	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—JAG2—pancreatic cancer	0.000473	0.000981	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MEN1—pancreatic cancer	0.000466	0.000966	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—JAG2—pancreatic cancer	0.000463	0.00096	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MEN1—pancreatic cancer	0.000456	0.000946	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000451	0.000876	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000448	0.000869	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SHH—pancreatic cancer	0.000445	0.000922	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOTCH4—pancreatic cancer	0.000442	0.000916	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Epirubicin—pancreatic cancer	0.000439	0.000853	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IAPP—pancreatic cancer	0.000439	0.000911	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SHH—pancreatic cancer	0.000435	0.000902	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000433	0.000897	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IAPP—pancreatic cancer	0.00043	0.000891	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTCH1—pancreatic cancer	0.000422	0.000874	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTHLH—pancreatic cancer	0.000422	0.000874	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Epirubicin—pancreatic cancer	0.000419	0.000813	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000417	0.00081	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTHLH—pancreatic cancer	0.000413	0.000856	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTCH1—pancreatic cancer	0.000413	0.000856	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Doxorubicin—pancreatic cancer	0.000406	0.000789	CcSEcCtD
Carboprost Tromethamine—Dizziness—Epirubicin—pancreatic cancer	0.000405	0.000786	CcSEcCtD
Carboprost Tromethamine—Vomiting—Epirubicin—pancreatic cancer	0.000389	0.000756	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000388	0.000753	CcSEcCtD
Carboprost Tromethamine—Rash—Epirubicin—pancreatic cancer	0.000386	0.00075	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Epirubicin—pancreatic cancer	0.000386	0.000749	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SST—pancreatic cancer	0.000386	0.000799	CbGpPWpGaD
Carboprost Tromethamine—Headache—Epirubicin—pancreatic cancer	0.000383	0.000745	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.00038	0.000788	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SST—pancreatic cancer	0.000377	0.000782	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—JAG1—pancreatic cancer	0.000377	0.000782	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOTCH3—pancreatic cancer	0.000376	0.000779	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Doxorubicin—pancreatic cancer	0.000375	0.000727	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000372	0.000772	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—JAG1—pancreatic cancer	0.000369	0.000766	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000368	0.000763	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Epirubicin—pancreatic cancer	0.000364	0.000706	CcSEcCtD
Carboprost Tromethamine—Vomiting—Doxorubicin—pancreatic cancer	0.00036	0.000699	CcSEcCtD
Carboprost Tromethamine—Rash—Doxorubicin—pancreatic cancer	0.000357	0.000694	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Doxorubicin—pancreatic cancer	0.000357	0.000693	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CNR1—pancreatic cancer	0.000356	0.000738	CbGpPWpGaD
Carboprost Tromethamine—Headache—Doxorubicin—pancreatic cancer	0.000355	0.000689	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CNR1—pancreatic cancer	0.000348	0.000722	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000345	0.000716	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GCG—pancreatic cancer	0.000344	0.000712	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000338	0.000701	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Doxorubicin—pancreatic cancer	0.000336	0.000653	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GCG—pancreatic cancer	0.000336	0.000697	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000334	0.000693	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AGTR1—pancreatic cancer	0.000328	0.00068	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000327	0.000678	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—STK11—pancreatic cancer	0.000323	0.00067	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AGTR1—pancreatic cancer	0.000321	0.000665	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—STK11—pancreatic cancer	0.000316	0.000656	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000304	0.000629	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000297	0.000616	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000291	0.000604	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000285	0.000591	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SMAD4—pancreatic cancer	0.000283	0.000587	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL8—pancreatic cancer	0.00028	0.000581	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SMAD4—pancreatic cancer	0.000277	0.000574	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HES1—pancreatic cancer	0.000276	0.000573	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000274	0.000568	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HES1—pancreatic cancer	0.00027	0.000561	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000265	0.000549	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000259	0.000537	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCL8—pancreatic cancer	0.000254	0.000527	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000249	0.000516	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TERT—pancreatic cancer	0.000242	0.000502	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TERT—pancreatic cancer	0.000237	0.000491	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HIF1A—pancreatic cancer	0.000232	0.00048	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TSC2—pancreatic cancer	0.000231	0.000479	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HIF1A—pancreatic cancer	0.000227	0.00047	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TSC2—pancreatic cancer	0.000226	0.000469	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOE—pancreatic cancer	0.000226	0.000469	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KDR—pancreatic cancer	0.000221	0.000459	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOE—pancreatic cancer	0.000221	0.000459	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KDR—pancreatic cancer	0.000217	0.000449	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NFKBIA—pancreatic cancer	0.000211	0.000437	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOTCH1—pancreatic cancer	0.000209	0.000432	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000206	0.000427	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000204	0.000423	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CG—pancreatic cancer	0.000204	0.000423	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—NRAS—pancreatic cancer	0.000204	0.000423	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EGF—pancreatic cancer	0.000202	0.000418	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CG—pancreatic cancer	0.0002	0.000414	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—NRAS—pancreatic cancer	0.0002	0.000414	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EGF—pancreatic cancer	0.000197	0.000409	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—pancreatic cancer	0.000186	0.000385	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—pancreatic cancer	0.000182	0.000377	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CD—pancreatic cancer	0.000179	0.000372	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000178	0.000368	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—KRAS—pancreatic cancer	0.000176	0.000364	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000176	0.000364	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000174	0.00036	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—KRAS—pancreatic cancer	0.000172	0.000356	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000161	0.000334	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000158	0.000327	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CB—pancreatic cancer	0.000156	0.000324	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CB—pancreatic cancer	0.000153	0.000317	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCL8—pancreatic cancer	0.00015	0.000311	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HRAS—pancreatic cancer	0.000149	0.000309	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCL8—pancreatic cancer	0.000147	0.000305	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HRAS—pancreatic cancer	0.000146	0.000303	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—pancreatic cancer	0.000145	0.000301	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CASP3—pancreatic cancer	0.000144	0.000298	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—pancreatic cancer	0.000142	0.000294	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CASP3—pancreatic cancer	0.000141	0.000292	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCND1—pancreatic cancer	0.00014	0.00029	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CTNNB1—pancreatic cancer	0.000139	0.000287	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCND1—pancreatic cancer	0.000137	0.000284	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MMP9—pancreatic cancer	0.000136	0.000282	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CTNNB1—pancreatic cancer	0.000136	0.000281	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTEN—pancreatic cancer	0.000135	0.00028	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MMP9—pancreatic cancer	0.000133	0.000276	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTEN—pancreatic cancer	0.000132	0.000274	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—pancreatic cancer	0.000132	0.000273	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—pancreatic cancer	0.000129	0.000267	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SRC—pancreatic cancer	0.000125	0.00026	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SRC—pancreatic cancer	0.000123	0.000254	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—pancreatic cancer	0.000122	0.000253	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—STAT3—pancreatic cancer	0.000121	0.00025	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NRAS—pancreatic cancer	0.000121	0.00025	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—pancreatic cancer	0.000119	0.000248	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—STAT3—pancreatic cancer	0.000118	0.000245	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NRAS—pancreatic cancer	0.000118	0.000245	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MYC—pancreatic cancer	0.000112	0.000233	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TGFB1—pancreatic cancer	0.000112	0.000232	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MYC—pancreatic cancer	0.00011	0.000228	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EGFR—pancreatic cancer	0.00011	0.000228	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TGFB1—pancreatic cancer	0.00011	0.000227	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EGFR—pancreatic cancer	0.000107	0.000223	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KRAS—pancreatic cancer	0.000104	0.000215	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KRAS—pancreatic cancer	0.000102	0.00021	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PIK3CA—pancreatic cancer	9.53e-05	0.000198	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PIK3CA—pancreatic cancer	9.33e-05	0.000193	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TP53—pancreatic cancer	9.22e-05	0.000191	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TP53—pancreatic cancer	9.02e-05	0.000187	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HRAS—pancreatic cancer	8.82e-05	0.000183	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HRAS—pancreatic cancer	8.63e-05	0.000179	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKT1—pancreatic cancer	7.78e-05	0.000161	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKT1—pancreatic cancer	7.62e-05	0.000158	CbGpPWpGaD
